Abstract:AIM:Hypoxic ischemia can lead to abnormal fetal growth and development.It has been shown that insulin-like growth factor binding protein 1（IGFBP1） is strongly associated with developmental delay in hypoxiastressed embryos.In this study,the model animal zebrafish was used to investigate the effect of IGFBP1 on embryonic development.METHODS:CRISPR/Cas9 technology was used to generate igfbp1a and igfbp1b gene mutants.The body length and survival rate of zebrafish embryos were measured at 24,48 and 72 hpf（hours post-fertilization）.RESULTS:Twelve different genotypes of igfbp1a -/- and six igfbp1b -/- mutants were successfully obtained.No abnormal phenotype was observed in mutant zebrafish.Mutants of igfbp1a（-13 bp） -/- and igfbp1b（-14 bp） -/- were used in further experiments.Exposing the wild-type（WT） embryos to the hypoxic environment for 24 h from 24,48 and 72 hpf lead to a significantly shorter body length（P＜0.01）.However,there was no obvious difference in the body length of igfbp1a -/- and igfbp1b -/- zebrafishes after hypoxia treatment compared with the normoxia group,suggesting that igfbp1a and igfbp1b are involved in abnormal embryonic development under hypoxia condition.Interestingly,igfbp1a -/- mutant had a higher survival rate than WT in hypoxia condition（P＜0.05）,while the survival rate was decreased in igfbp1b -/- mutant embryos.CONCLUSION:igfbp1 deletion can rescue the inhibition of embryonic development by hypoxia,suggesting that IGFBP1 is a potential molecular target for the treatment of hypoxic-ischemic embryonic injury disease.

Generation and phenotypic analysis of zebrafish igfbp1 mutants